Interferon α down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells

Blood

Volumn 96, Issue 13, 2000, Pages 4313-4318

  Xu, Dawei ^b   Erickson, Sven ^b   Szeps, Michael ^b   Gruber, Astrid ^b   Sangfelt, Olle ^b   Einhorn, Stefan ^b   Pisa, Pavel ^b   Grandér, Dan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; CYCLOHEXIMIDE; DNA; DNA BINDING PROTEIN; MESSENGER RNA; PROTEIN SYNTHESIS INHIBITOR; RNA; TELOMERASE; TELOMERASE RNA; TUMOR PROTEIN;

ACUTE DISEASE; ARTICLE; BIOSYNTHESIS; BURKITT LYMPHOMA; CELL CULTURE; CELL CYCLE; CHEMICAL PHENOMENA; COMPARATIVE STUDY; CUTANEOUS T CELL LYMPHOMA; DNA REPLICATION; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MULTIPLE MYELOMA; MYELOID LEUKEMIA; PATHOLOGY; T CELL LEUKEMIA; T LYMPHOCYTE;

ACUTE DISEASE; ANTINEOPLASTIC AGENTS; BURKITT LYMPHOMA; CELL CYCLE; CYCLOHEXIMIDE; DEPRESSION, CHEMICAL; DNA REPLICATION; DNA, NEOPLASM; DNA-BINDING PROTEINS; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON ALFA-2B; LEUKEMIA, MYELOID; LEUKEMIA, T-CELL, ACUTE; LYMPHOMA, T-CELL, CUTANEOUS; MULTIPLE MYELOMA; NEOPLASM PROTEINS; PROTEIN SYNTHESIS INHIBITORS; RNA; RNA, MESSENGER; RNA, NEOPLASM; T-LYMPHOCYTES; TELOMERASE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034672243     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.13.4313.h8004313_4313_4318     Document Type: Article

References (18)

1. Harley CB, Kim NW, Prowse KR, et al. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol. 1994;59:307-315.
2. Feng L, Funk WD, Wang, S-S, et al. The RNA component of human telomerase. Science. 1995;269:1236-1241.
3. Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 1997;90:785-795.
4. Pfeffer LM. Biological properties of recombinant α-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 1998;58:2489-2499.
5. Einhorn S, Strander H. Interferon treatment of human malignancies - a short review. Med Oncol Tumor Pharmacother. 1993;10:25-29.
6. Sangfelt O, Erickson S, Castro J, Heiden T, Einhorn S, Grandér D. Induction of apoptosis and inhibition of cell growth are independent responses to interteron-α in hematopoietic cell lines. Cell Growth Diff. 1997;8:343-352.
7. Sangfelt O, Erickson S, Castro J, et al. Molecular mechanisms underlying interferon-α-induced G0/G1 arrest: CKI-medialed regulation of G1 Cdk-complex and activation of pocket proteins. Oncogene. 1999;18:2798-2810.
8. Erickson S, Sangfelt O, Castro J, Einhorn S, Grander D, et al. Interferon-α inhibits proliferation in human T-lymphocytes by abrogation of IL-2 induced changes in cell cycle regulatory proteins. Cell Growth Diff. 1999;10:575-582.
9. Xu D, Gruber A, Peterson C, Pisa P. Suppression of telomerase reverse transcriptase (hTERT) in differentiated HL60 cells: regulatory mechanisms Br J Cancer. 1999;8:1156-1161.
10. Xu D, Gruber A, Peterson C, Pisa P. Suppression of telomerase activity in HL60 cells after treatment with differentiating agents. Leukemia. 1996;10:1354-1357.
11. Greider CW. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci U S A. 1998;95:90-92.
12. Sangfelt O, Erickson S, Einhorn S, Grandér D. Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-α in hematopoietic cell lines. Oncogene. 1997;14:415-423.
13. Greider CW. Telomerase activation one step on the road to cancer. Trends Genet. 1999;15:109-112.
14. Liu K, Schoonmaker MM, Levine BL, June CH, Hodes RJ, Weng NP. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc Natl Acad Sci U S A. 1999;96:5147-5152.
15. Fujimoto K, Takahashi M. Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA. Biochem Biophys Res Commun. 1997;241:775-781.
16. Wang J, Xie LY, Allan S, Beach D, Hannon GJ. Myc activates telomerase. Genes Dev. 1998;12:1769-1774.
17. Cong Y-S, Wen J, Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet. 1999;8:137-142.
18. Xiao X, Bardot V, Wientjes M, Au J. Cell death is accompanied by an increase in telomerase activity. Proc Am Assoc Cancer Res. 1996;37:560.